BIOMARKER RESEARCH SERVICES MARKET ANALYSIS

One of the major challenges hindering the growth of the global biomarker research services market is the high costs associated with biomarker research and development. Biomarker discovery and validation is an expensive process as it requires advanced techniques such as proteomics, genomics, and metabolomics for the identification of potential biomarkers. Moreover, clinical validation of biomarkers through animal and human studies further increases R&D costs. Developing a single biomarker typically costs between US$ 5 and US$ 10 million and can sometimes exceed US$ 50 million depending on the complexity.

Market Opportunity - Expansion of biomarker applications in drug discovery and development

One of the major opportunities for the global biomarker research services market is the expanding role of biomarkers in drug discovery and development processes. Biomarkers are increasingly becoming indispensable tools in pharmaceutical R&D as they help accelerate drug development by reducing costs and improving success rates. Biomarkers aid in identifying disease subtypes, monitoring drug responses, selecting right patient populations for clinical trials, and determining which new drug candidates are worth pursuing in late-stage trials.